Phibro Animal Health
PAHC
131 hedge funds and large institutions have $261M invested in Phibro Animal Health in 2022 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 59 increasing their positions, 40 reducing their positions, and 28 closing their positions.
94% more call options, than puts
Call options by funds: $60K | Put options by funds: $31K
48% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 40
1% less capital invested
Capital invested by funds: $265M → $261M (-$3.8M)
2.26% less ownership
Funds ownership: 97.99% → 95.73% (-2.3%)
12% less funds holding
Funds holding: 149 → 131 (-18)
57% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$5.91M |
| 2 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$3.14M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.14M |
| 4 |
Morgan Stanley
New York
|
+$2.46M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$6.1M |
| 2 |
DRZID
DePrince Race & Zollo Inc (DRZ)
Winter Park,
Florida
|
-$3.51M |
| 3 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
-$3.27M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$3.11M |
| 5 |
PAIM
Punch & Associates Investment Management
Edina,
Minnesota
|
-$2.95M |
PAHC Hedge Fund Activity: Q4 2022 in Review
131 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q4 2022, worth a combined $261M — down 1.4% from $265M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of PAHC and 12 opened new positions — a net loss of 16 holders — while 40 trimmed existing stakes and 59 added.
The largest buyer was Brandes Investment Partners, adding an estimated $5.91M. The largest seller was Millennium Management, cutting an estimated $6.1M.
- 131 institutional investors held Phibro Animal Health (PAHC) as of Q4 2022, down from 149 in Q3 2022.
- Funds reported $261M of Phibro Animal Health stock for Q4 2022, down 1.4% quarter-over-quarter.
- 12 funds opened new Phibro Animal Health positions in Q4 2022 and 28 closed out, a net change of -16 holders.
- The largest Phibro Animal Health buyer in Q4 2022 was Brandes Investment Partners, an estimated $5.91M added.
- The largest Phibro Animal Health seller in Q4 2022 was Millennium Management, an estimated $6.1M sold.
Based on aggregated 13F filings for Q4 2022.